Publications

Filter Year

New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study.
Mouchahoir T, Schiel JE, Rogers R, Heckert A, Place BJ, Ammerman A, Li X, Robinson T, Schmidt B, Chumsae CM, et al. 2021. New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study. Journal of the American Society for Mass Spectrometry 32(4): 913-928. DOI: 10.1021/jasms.0c00415
Recombinant expression of computationally designed peptide-bundlemers in Escherichia coli.
Sinha NJ, Kloxin CJ, Saven JG, Jensen GV, Kelman Z, Pochan DJ. 2021. Recombinant expression of computationally designed peptide-bundlemers in Escherichia coli. Journal of biotechnology 330: 57-60. DOI: 10.1016/j.jbiotec.2021.03.004
Engineering subtilisin proteases that specifically degrade active RAS.
Chen Y, Toth EA, Ruan B, Choi EJ, Simmerman R, Chen Y, He Y, Wang R, Godoy-Ruiz R, King H, et al. 2021. Engineering subtilisin proteases that specifically degrade active RAS. Communications biology 4(1): 299. DOI: 10.1038/s42003-021-01818-7
Multimeric antibodies from antigen-specific human IgM+ memory B cells restrict Plasmodium parasites.
Thouvenel CD, Fontana MF, Netland J, Krishnamurty AT, Takehara KK, Chen Y, Singh S, Miura K, Keitany GJ, Lynch EM, et al. 2021. Multimeric antibodies from antigen-specific human IgM+ memory B cells restrict Plasmodium parasites. The Journal of experimental medicine 218(4): . DOI: 10.1084/jem.20200942
First Report of Xanthomonas fragariae strain YL19 causing crown infection pockets in strawberry in Liaoning Province, China.
Feng J, Li YL, Wang DJ, Ma Y, Cai X, Xiao S, Wen Y. 2021. First Report of <i>Xanthomonas fragariae</i> strain YL19 causing crown infection pockets in strawberry in Liaoning Province, China. Plant disease : . DOI: 10.1094/PDIS-12-20-2560-PDN
Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
Brandis JEP, Kihn KC, Taraban MB, Schnorr J, Confer AM, Batelu S, Sun D, Rodriguez JD, Jiang W, Goldberg DP, et al. 2021. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate. Molecular pharmaceutics 18(4): 1544-1557. DOI: 10.1021/acs.molpharmaceut.0c00922
Structural and biochemical insights into flavivirus proteins.
Dey D, Poudyal S, Rehman A, Hasan SS. 2021. Structural and biochemical insights into flavivirus proteins. Virus research 296: 198343. DOI: 10.1016/j.virusres.2021.198343
Overexpression of two CDPKs from wild Chinese grapevine enhances powdery mildew resistance in Vitis vinifera and Arabidopsis.
Hu Y, Cheng Y, Yu X, Liu J, Yang L, Gao Y, Ke G, Zhou M, Mu B, Xiao S, et al. 2021. Overexpression of two CDPKs from wild Chinese grapevine enhances powdery mildew resistance in Vitis vinifera and Arabidopsis. The New phytologist 230(5): 2029-2046. DOI: 10.1111/nph.17285
Intracellular Delivery of Active Proteins by Polyphosphazene Polymers.
Qamar B, Solomon M, Marin A, Fuerst TR, Andrianov AK, Muro S. 2021. Intracellular Delivery of Active Proteins by Polyphosphazene Polymers. Pharmaceutics 13(2): . DOI: 10.3390/pharmaceutics13020249
Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP.
Valencia SM, Zacharia A, Marin A, Matthews RL, Wu CK, Myers B, Sanders C, Difilippantonio S, Kirnbauer R, Roden RB, et al. 2021. Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP. Human vaccines & immunotherapeutics 17(8): 2748-2761. DOI: 10.1080/21645515.2021.1875763
Grand Challenges in Pharmaceutical Research Series: Ridding the Cold Chain for Biologics.
Yu YB, Briggs KT, Taraban MB, Brinson RG, Marino JP. 2021. Grand Challenges in Pharmaceutical Research Series: Ridding the Cold Chain for Biologics. Pharmaceutical research 38(1): 3-7. DOI: 10.1007/s11095-021-03008-w
Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization.
Wang Y, Howell KA, Brannan J, Agans KN, Turner HL, Wirchnianski AS, Kailasan S, Fusco M, Galkin A, Chiang CI, et al. 2021. Prominent Neutralizing Antibody Response Targeting the <i>Ebolavirus</i> Glycoprotein Subunit Interface Elicited by Immunization. Journal of virology : . DOI: 10.1128/JVI.01907-20
An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants.
Guest JD, Vreven T, Zhou J, Moal I, Jeliazkov JR, Gray JJ, Weng Z, Pierce BG. 2021. An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants. Structure (London, England : 1993) 29(6): 606-621.e5. DOI: 10.1016/j.str.2021.01.005
Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design.
Amcheslavsky A, Wallace AL, Ejemel M, Li Q, McMahon CT, Stoppato M, Giuntini S, Schiller ZA, Pondish JR, Toomey JR, et al. 2021. Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design. Scientific reports 11(1): 2751. DOI: 10.1038/s41598-021-81895-0
Application of bacteriophage-derived endolysins to combat streptococcal disease: current state and perspectives.
Linden SB, Alreja AB, Nelson DC. 2021. Application of bacteriophage-derived endolysins to combat streptococcal disease: current state and perspectives. Current opinion in biotechnology 68: 213-220. DOI: 10.1016/j.copbio.2021.01.012